...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: ... here's a little tidbit...

That's an interesting question SF....70% of how many events?  The original protocol was 2,400 particiapants with completion determined at 250 MAC events and a Fultitily analysis at the 1/2 way point, or 125 events.

Now there's the question of increasing the patient population.....but would 250 MAC events still be considered the completion point...or would that be increased as well?  

In any event...and as Kelsee pointed out yesterday, we're now due for at least another interim analysis by the DSMB.  I'd prefer a Futility Analysis, but at least another update from the board would be something positive....so long as they continue reccomending that the trial continue while noting no safety or efficacy issues.  

Share
New Message
Please login to post a reply